Mechanisms underlying the vulnerability of striatal dopaminergic neurons caused by stress-related mental disorders.
Project/Area Number |
24790096
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
|
Research Institution | Hokuriku University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Keywords | パーキンソン病 / ストレス性精神障害 / ドパミン神経 / MPTP / シナプトソーム |
Research Abstract |
In order to establish the functional assay system for dopaminergic terminals in striatal synaptosomes, we use the fluorescent compound 4-(4-diethylaminostyryl)-N-methylpyridinium iodide (ASP+). ASP+ has been used to measure the biophysical properties of norepinephrine transporter (NET), serotonin transporter (SERT) or dopamine transporter (DAT). In this study, we have investigated whether ASP+ can be used as a fluorescent substrate to monitor DAT function in mouse striatal synaptosomes. We confirmed the specificity of ASP+ uptake for the NET, SERT and DAT using several inhibitors of monoamine transporters in synaptosomes prepared from the striatum and frontal cortex. These results suggest that the ASP+ method might be used to evaluate for the function of dopaminergic terminals in striatal synaptosomes.
|
Report
(3 results)
Research Products
(12 results)